Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5682170 | 0.91 | — | — | |
| SCHEMBL5678015 | 0.77 | SMN1; SMN2 (0.46) | ALDH1A1CYP1A2LMNAKMT2AL3MBTL1 | |
| SCHEMBL5678098 | 0.77 | DYRK1A (0.38) | ALDH1A1HTR2AHTR2CHTR2B | |
| SCHEMBL7778389 | 0.74 | SLC22A12 (0.35) | PTGS2ALDH1A1LMNAKMT2AL3MBTL1 | |
| SCHEMBL905952 | 0.74 | HTR2A (0.35) | PTGS2HTR2AHTR2CCYP1A2CYP3A4 | |
| SCHEMBL5678034 | 0.71 | PTGDR2 (0.34) | HTR2AHTR2C | |
| Fumaric Acid SCHEMBL5682016 | 0.70 | HTR2A (0.41) | HTR2AHTR2CCYP1A2CYP3A4CYP2C9 | |
| Fumaric Acid SCHEMBL5682001 | 0.70 | HTR2A (0.41) | HTR2AHTR2CCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5682015 | 0.67 | SLC22A12 (0.32) | ALDH1A1HTR2AHTR2CHTR2BKMT2A | |
| SCHEMBL7779507 | 0.67 | SLC22A12 (0.32) | ALDH1A1HTR2AHTR2CHTR2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1129078-B1 | INDAZOLE DERIVATIVES WITH 5-HT2 RECEPTOR ACTIVITY | VERNALIS RES LTD (GB) | 2006-03-15 | — | — | EP | disclosed |
| US-6552062-B1 | For therapy of central nervous system disorders; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and obesity | VERNALIS RESEARCH LIMITED (GB) | 2003-04-22 | — | — | US | disclosed |